Ipsen (IPSEF) YoY Rev. per Sh. Growth: 22.33% (As of Dec. 2025)


IPSEF Ipsen SA IPSEF
95 GF Score
Price $113.13
GF Value $92.81
! 7 Warning Signs
View Full Analysis

What is Ipsen YoY Rev. per Sh. Growth?

Ipsen IPSEF 95 YoY Rev. per Sh. Growth is 22.33% as of Dec. 2025. GuruFocus rates IPSEF with a GF Score™ of 95/100 and a GF Value™ of $92.81. The stock has 7 warning signs investors should review.

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Ipsen's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2025 was 22.33%.

Ipsen's Revenue per Share for the six months ended in Dec. 2025 was $28.02.

Ipsen YoY Rev. per Sh. Growth Historical Data

* Premium members only.

The historical data trend for Ipsen's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ipsen YoY Rev. per Sh. Growth Chart

Ipsen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.85 8.00 7.47 3.79 22.95

Ipsen Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 6.74 4.42 18.42 22.33
IPSEF
95GF Score
Ipsen SA IPSEF
YoY Rev. per Sh. Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ipsen YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Ipsen's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2025 )
=(Revenue per Share (A: Dec. 2025 )-Revenue per Share (A: Dec. 2024 ))/ | Revenue per Share (A: Dec. 2024 ) |
=(55.183-44.884)/ | 44.884 |
=22.95 %

Ipsen's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2025 )
=(Revenue per Share (Q: Dec. 2025 )-Revenue per Share (Q: Dec. 2024 )) / | Revenue per Share (Q: Dec. 2024 )) |
=(28.019-22.904)/ | 22.904 |
=22.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a YoY Rev. per Sh. Growth of 22.33% mean?
Ipsen (IPSEF) has a YoY Rev. per Sh. Growth of 22.33% as of Dec. 2025. YoY Rev. per Sh. Growth is the percentage change of revenue per share over the past 12-month. View historical data for Ipsen and its competitors.
Is Ipsen's YoY Rev. per Sh. Growth too high?
Ipsen's current YoY Rev. per Sh. Growth is 22.33%. Overall, Ipsen has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Ipsen's YoY Rev. per Sh. Growth compare to ZTS and UTHR?
Ipsen's YoY Rev. per Sh. Growth of 22.33% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY Rev. per Sh. Growth for a Drug Manufacturers company?
A good YoY Rev. per Sh. Growth depends on the Drug Manufacturers industry context. However, YoY Rev. per Sh. Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY Rev. per Sh. Growth mean?
A high YoY Rev. per Sh. Growth can signal that a stock is expensive relative to its fundamentals. YoY Rev. per Sh. Growth is the percentage change of revenue per share over the past 12-month. View historical data for Ipsen and its competitors. Ipsen's current YoY Rev. per Sh. Growth is 22.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipsen stock overvalued right now?
Ipsen (IPSEF) has a current YoY Rev. per Sh. Growth of 22.33%. The stock's GF Value™ is $92.81, compared to a current price of $113.13 — trading 21.9% above its estimated fair value. The current YoY Rev. per Sh. Growth is 22.33%. Ipsen's overall GF Score™ is 95/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY Rev. per Sh. Growth calculated?
YoY Rev. per Sh. Growth is calculated from a company's financial statements. For Ipsen (IPSEF), the current YoY Rev. per Sh. Growth is 22.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ipsen (IPSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Ipsen stock appears to be overvalued. The current stock price of $113.13 is trading 21.9% above its estimated GF Value™ of $92.81.

Key valuation signals for IPSEF:

  • YoY Rev. per Sh. Growth: 22.33%
  • GF Value™: $92.81 vs. price of $113.13 (21.9% above fair value)
  • GF Score™: 95/100 with 7 warning signs

No single metric tells the full story. See the IPSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipsen Business Description

Address 70 rue Balard, Paris, FRA, 75015
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score

Get the complete analysis for IPSEF

YoY Rev. per Sh. Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$113.13
Price
$92.81
GF Value